Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benapenem in Complicated Urinary Tract Infection or Acute Pyelonephritis
NCT04505683Phase 3Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Dec 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of benapenem in complicated urinary tract infection (cUTI) and acute pyelonephritis (2 arms), sponsored by Sihuan Pharmaceutical. Primary endpoint: Percentage of patients with clinical cure at test-of-cure (TOC) visit. Started Dec 2018; status: completed.
02
Drugs
benapenem
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT04505683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505683.